Home
JAZZ
JAZZ News

Latest Jazz Pharmaceuticals plc (Ireland) (JAZZ) News on March 29, 2025

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?

Zacks

2 days ago

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?

Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

PR Newswire

3 days ago

Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey

4 days ago

Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term

Zacks

5 days ago

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term

Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride

Zacks

5 days ago

Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride

TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside

TipRanks

7 days ago

TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside

5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes

Zacks

8 days ago

5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes

Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect?

Zacks

10 days ago

Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect?

3 Value Stocks Skating on Thin Ice

StockStory

10 days ago

3 Value Stocks Skating on Thin Ice

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting

PR Newswire

10 days ago

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting

Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points

Investor's Business Daily

12 days ago

Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points

JAZZ or ILMN: Which Is the Better Value Stock Right Now?

Zacks

15 days ago

JAZZ or ILMN: Which Is the Better Value Stock Right Now?

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?

Zacks

15 days ago

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

Zacks

15 days ago

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

MT Newswires

17 days ago

Jazz Pharmaceuticals Insider Sold Shares Worth $332,605, According to a Recent SEC Filing

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Zacks

17 days ago

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day

Zacks

17 days ago

Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day

Bull of the Day: Jazz Pharmaceuticals (JAZZ)

Zacks

17 days ago

Bull of the Day: Jazz Pharmaceuticals (JAZZ)

4 Discounted PEG Stocks Offering the Best Returns to Value Investors

Zacks

19 days ago

4 Discounted PEG Stocks Offering the Best Returns to Value Investors

Why Chimerix, Inc. (CMRX) Soared Last Week

Insider Monkey

20 days ago

Why Chimerix, Inc. (CMRX) Soared Last Week

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Zacks

22 days ago

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

Zacks

23 days ago

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

MT Newswires

23 days ago

Update: Truist Raises PT on Jazz Pharmaceuticals to $230 From $220 on Heels of Announced Purchase of Chimerix, Keeps Buy Rating

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Zacks

23 days ago

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Beat Market Volatility With 4 Low-Beta Stocks: PGR, PSO, TXO & JAZZ

Zacks

23 days ago

Beat Market Volatility With 4 Low-Beta Stocks: PGR, PSO, TXO & JAZZ

MT Newswires

23 days ago

Truist Raises Price Target on Jazz Pharmaceuticals to $230 From $220, Keeps Buy Rating

3 Highly Ranked Medical Stocks to Buy Amid Recent Market Volatility: JAZZ, OPCH, PCRX,

Zacks

24 days ago

3 Highly Ranked Medical Stocks to Buy Amid Recent Market Volatility: JAZZ, OPCH, PCRX,

Jazz Pharmaceuticals bids for Chimerix in $935m deal

Pharmaceutical Technology

24 days ago

Jazz Pharmaceuticals bids for Chimerix in $935m deal

MT Newswires

24 days ago

Chimerix a Prime Acquisition Candidate for Jazz Pharmaceuticals Due to Dordaviprone, Wedbush Says

Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still Room to Run?

Zacks

24 days ago

Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still Room to Run?

MT Newswires

24 days ago

Jazz Pharmaceuticals to Acquire Chimerix in $935 Million Deal

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

PR Newswire

24 days ago

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

Jazz expands in oncology with $935M deal for Chimerix

BioPharma Dive

24 days ago

Jazz expands in oncology with $935M deal for Chimerix

Statutory Profit Doesn't Reflect How Good Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings Are

Simply Wall St.

24 days ago

Statutory Profit Doesn't Reflect How Good Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings Are

Zacks.com featured highlights include EverQuote, Jazz Pharmaceuticals, The Progressive, Sony and NatWest

Zacks

24 days ago

Zacks.com featured highlights include EverQuote, Jazz Pharmaceuticals, The Progressive, Sony and NatWest

3 Small-Cap Stocks Skating on Thin Ice

StockStory

25 days ago

3 Small-Cap Stocks Skating on Thin Ice

Jazz Pharmaceuticals plc (JAZZ): Among the Cash-Rich Mid Cap Stocks to Buy Now

Insider Monkey

a month ago

Jazz Pharmaceuticals plc (JAZZ): Among the Cash-Rich Mid Cap Stocks to Buy Now

Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?

Zacks

a month ago

Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?

Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?

Zacks

a month ago

Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?

4 Stocks Trading Near 52-Week High With More Upside Potential

Zacks

a month ago

4 Stocks Trading Near 52-Week High With More Upside Potential

Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?

Zacks

a month ago

Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?

International Markets and Jazz (JAZZ): A Deep Dive for Investors

Zacks

a month ago

International Markets and Jazz (JAZZ): A Deep Dive for Investors

Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.

a month ago

Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Morningstar Research

a month ago

Analyst Report: Jazz Pharmaceuticals plc

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Zacks

a month ago

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

MT Newswires

a month ago

RBC Trims Price Target on Jazz Pharmaceuticals to $178 From $179, Keeps Outperform Rating

Despite the downward trend in earnings at Jazz Pharmaceuticals (NASDAQ:JAZZ) the stock advances 3.2%, bringing five-year gains to 21%

Simply Wall St.

a month ago

Despite the downward trend in earnings at Jazz Pharmaceuticals (NASDAQ:JAZZ) the stock advances 3.2%, bringing five-year gains to 21%

Jazz Pharmaceuticals PLC (JAZZ) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com

a month ago

Jazz Pharmaceuticals PLC (JAZZ) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

Argus Research

a month ago

JAZZ: Raising target price to $154.00

Compared to Estimates, Jazz (JAZZ) Q4 Earnings: A Look at Key Metrics

Zacks

a month ago

Compared to Estimates, Jazz (JAZZ) Q4 Earnings: A Look at Key Metrics

Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates

Zacks

a month ago

Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates

Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 Sales

StockStory

a month ago

Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 Sales

MT Newswires

a month ago

Jazz Pharmaceuticals Q4 Non-GAAP Earnings, Revenue Rise; 2025 Guidance Issued

Associated Press Finance

a month ago

Jazz: Q4 Earnings Snapshot

Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect

StockStory

a month ago

Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect

Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference

PR Newswire

a month ago

Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference

Jazz (JAZZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks

a month ago

Jazz (JAZZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Argus Research

a month ago

JAZZ: Raising target price to $149.00

Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?

Zacks

a month ago

Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?

Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025

PR Newswire

2 months ago

Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025

Why Jazz (JAZZ) is Poised to Beat Earnings Estimates Again

Zacks

2 months ago

Why Jazz (JAZZ) is Poised to Beat Earnings Estimates Again

Argus Research

2 months ago

JAZZ: Lowering target price to $134.00

Argus Research

2 months ago

JAZZ: Raising target price to $136.00

Argus Research

2 months ago

JAZZ: Lowering target price to $133.00

JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline

Clinical Trials Arena

2 months ago

JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline

Jazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks Now

Insider Monkey

2 months ago

Jazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks Now

Argus Research

2 months ago

JAZZ: What does Argus have to say about JAZZ?

Argus Research

3 months ago

JAZZ: Raising target price to $137.00

Argus Research

3 months ago

JAZZ: Raising target price to $135.00

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

3 months ago

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MT Newswires

3 months ago

Jazz Pharmaceuticals CEO Bruce Cozadd Plans to Retire

Jazz Pharmaceuticals Announces CEO Succession Plan

PR Newswire

3 months ago

Jazz Pharmaceuticals Announces CEO Succession Plan

MT Newswires

3 months ago

Truist Securities Adjusts Jazz Pharmaceuticals Public Price Target to $220 From $200, Maintains Buy Rating

Is Now The Time To Put Jazz Pharmaceuticals (NASDAQ:JAZZ) On Your Watchlist?

Simply Wall St.

3 months ago

Is Now The Time To Put Jazz Pharmaceuticals (NASDAQ:JAZZ) On Your Watchlist?

Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch

TipRanks

4 months ago

Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch

5 High ROE Stocks to Buy as Volatility Weighs on Markets

Zacks

4 months ago

5 High ROE Stocks to Buy as Volatility Weighs on Markets

Argus Research

4 months ago

JAZZ: Lowering target price to $132.00

MT Newswires

4 months ago

Jazz Pharmaceuticals Likely to Launch FDA-Approved Biliary Tract Cancer Treatment in 2025, RBC Says

Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting

PR Newswire

4 months ago

Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting

Jazz (JAZZ) Up 3.4% Since Last Earnings Report: Can It Continue?

Zacks

4 months ago

Jazz (JAZZ) Up 3.4% Since Last Earnings Report: Can It Continue?

Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii (Ziihera®)

PR Newswire

4 months ago

Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii (Ziihera®)

Jazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii) Investor Webcast on December 11, 2024

PR Newswire

4 months ago

Jazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii) Investor Webcast on December 11, 2024

Argus Research

4 months ago

JAZZ: Lowering target price to $134.00

Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting

PR Newswire

4 months ago

Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting

Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet

Zacks

4 months ago

Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet

Why Jazz Pharmaceuticals (JAZZ) Is One of the Most Undervalued Pot Stocks to Buy?

Insider Monkey

4 months ago

Why Jazz Pharmaceuticals (JAZZ) Is One of the Most Undervalued Pot Stocks to Buy?

Argus Research

4 months ago

JAZZ: Rating increased to a BUY

ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run?

Zacks

4 months ago

ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run?

Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler

TipRanks

4 months ago

Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler

MT Newswires

4 months ago

Sector Update: Health Care Stocks Rise Pre-Bell Thursday

MT Newswires

4 months ago

Sector Update: Health Care

MT Newswires

4 months ago

Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer

MT Newswires

4 months ago

Jazz Pharmaceuticals Receives US FDA Accelerated Approval for Biliary Tract Cancer Treatment

Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)

PR Newswire

4 months ago

Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)

Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference

PR Newswire

4 months ago

Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference

MT Newswires

4 months ago

UBS Raises Price Target on Jazz Pharmaceuticals Public to $128 From $121, Maintains Neutral Rating

Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?

Zacks

4 months ago

Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?

Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment

Insider Monkey

4 months ago

Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment

Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?

Insider Monkey

4 months ago

Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?

Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock?

Zacks

4 months ago

Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock?

Share on Social Networks: